Myriad Genetics Inc (MYGN)
18.65
-0.27
(-1.43%)
USD |
NASDAQ |
Apr 17, 16:00
18.65
0.00 (0.00%)
After-Hours: 16:14
Myriad Genetics 1 Year Total Returns (Daily): -15.04% for April 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 16, 2024 | -15.04% |
April 15, 2024 | -13.92% |
April 12, 2024 | -12.68% |
April 11, 2024 | -10.83% |
April 10, 2024 | -13.71% |
April 09, 2024 | -10.50% |
April 08, 2024 | -12.82% |
April 05, 2024 | -12.90% |
April 04, 2024 | -14.25% |
April 03, 2024 | -14.56% |
April 02, 2024 | -13.90% |
April 01, 2024 | -7.71% |
March 28, 2024 | -6.53% |
March 27, 2024 | -8.19% |
March 26, 2024 | -9.40% |
March 25, 2024 | -7.34% |
March 22, 2024 | -2.92% |
March 21, 2024 | -4.66% |
March 20, 2024 | -6.36% |
March 19, 2024 | -6.41% |
March 18, 2024 | -6.28% |
March 15, 2024 | -9.30% |
March 14, 2024 | -6.66% |
March 13, 2024 | -0.65% |
March 12, 2024 | 1.60% |
Date | Value |
---|---|
March 11, 2024 | 6.36% |
March 08, 2024 | 3.48% |
March 07, 2024 | 5.12% |
March 06, 2024 | 3.85% |
March 05, 2024 | -4.43% |
March 04, 2024 | -5.55% |
March 01, 2024 | 3.55% |
February 29, 2024 | 10.62% |
February 28, 2024 | 14.22% |
February 27, 2024 | 25.74% |
February 26, 2024 | 23.68% |
February 23, 2024 | 21.69% |
February 22, 2024 | 25.20% |
February 21, 2024 | 26.02% |
February 20, 2024 | 21.01% |
February 16, 2024 | 23.74% |
February 15, 2024 | 22.55% |
February 14, 2024 | 24.99% |
February 13, 2024 | 12.39% |
February 12, 2024 | 23.59% |
February 09, 2024 | 17.77% |
February 08, 2024 | 17.29% |
February 07, 2024 | 12.20% |
February 06, 2024 | 18.15% |
February 05, 2024 | 9.47% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-73.94%
Minimum
Aug 04 2020
202.0%
Maximum
Mar 17 2021
1.60%
Average
-18.36%
Median
1 Year Total Returns (Daily) Benchmarks
Stryker Corp | 16.91% |
Haemonetics Corp | -0.72% |
Perspective Therapeutics Inc | 126.4% |
Electromed Inc | 34.52% |
Xtant Medical Holdings Inc | 31.55% |